Canadian Journal of Gastroenterology (Jan 2010)
A One-Year Economic Evaluation of Six Alternative Strategies for the Management of Uninvestigated Upper Gastrointestinal Symptoms in Canadian Primary Care
- Alan N Barkun,
- Ralph Crott,
- Carlo A Fallone,
- Wendy A Kennedy,
- Jean Lachaine,
- Carey Levinton,
- David Armstrong,
- Naoki Chiba,
- Alan Thomson,
- Sander Veldhuyzen van Zanten,
- Paul Sinclair,
- Sergio Escobedo,
- Bijan Chakraborty,
- Sandra Smyth,
- Robert White,
- Helen Kalra,
- Krista Nevin
Affiliations
- Alan N Barkun
- Division of Gastroenterology, McGill University, Montréal, Quebec, Canada
- Ralph Crott
- Cliniques Universitaires St-Luc, Catholic University of Louvain, Brussels, Belgium
- Carlo A Fallone
- Division of Gastroenterology, McGill University, Montréal, Quebec, Canada
- Wendy A Kennedy
- Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada
- Jean Lachaine
- Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada
- Carey Levinton
- Division of Gastroenterology, McGill University, Montréal, Quebec, Canada
- David Armstrong
- Division of Gastroenterology, McMaster University, Hamilton, Canada
- Naoki Chiba
- Division of Gastroenterology, McMaster University, Hamilton, Canada
- Alan Thomson
- University of Alberta, Edmonton, Alberta, Canada
- Sander Veldhuyzen van Zanten
- Dalhousie University, Halifax, Nova Scotia, Canada
- Paul Sinclair
- INSINConsulting, Guelph, Canada
- Sergio Escobedo
- AstraZeneca Canada Inc, Mississauga, Ontario, Canada
- Bijan Chakraborty
- AstraZeneca Canada Inc, Mississauga, Ontario, Canada
- Sandra Smyth
- AstraZeneca Canada Inc, Mississauga, Ontario, Canada
- Robert White
- AstraZeneca Canada Inc, Mississauga, Ontario, Canada
- Helen Kalra
- AstraZeneca Canada Inc, Mississauga, Ontario, Canada
- Krista Nevin
- AstraZeneca Canada Inc, Mississauga, Ontario, Canada
- DOI
- https://doi.org/10.1155/2010/379583
- Journal volume & issue
-
Vol. 24,
no. 8
pp. 489 – 498
Abstract
BACKGROUND: The cost-effectiveness of initial strategies in managing Canadian patients with uninvestigated upper gastrointestinal symptoms remains controversial.
